Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

Drug Interaction between Cimetidine and Diltiazem in Rabbits

가토에서 딜티아젬과 시메티딘과의 약물상호작용

  • Published : 2002.09.20
Download PDF
⟨ Previous Next ⟩

Abstract

Diltiazem inhibits calcium channels and Iεads to vascular smooth muscle rεlaxation and negative inotropic and chronotropic effects in the hεart. Diltiazem is almost completely absorbεd after oral administration, but its extent of absolute oral bioavailability is reduced because of considerable first-pass hepatic metabolism. Diltiazem is able to dilate renal vasculature and can increase the glomerular filtration rate and renal sodium excretion. The purpose of this study was to report the pharmacokinetic changes of diltiazem after oral administration of diltiazem, 20 mg/kg, in rabbits coadministered with cimetidine, 20 mg/kg and pretreated twice per day for 3 days at cimetidine dose of 20 mg/kg. The area under the plasma concentration-time curve (AUC) of diltiazem was significantly higher in rabbits pretreated with cimetidine than that in control rabbits (p<0.01), showing about 149% increased relative bioavailability. The peak plasma concentration $(C_{max})$ and elimination half-life of diltiazem were increased significantly (p<0.05) in rabbits pretreated with cimetidine compared with those in control rabbits. This findings could be due to significant reduction of elimination rate constant by pretreated with cimetidine. The effects of cimetidine on the pharmacokinetics of oral diltiazem were more considerable in rabbits pretreated with cimetidine compared with those in control rabbits. The results suggest that the dosage of diltiazem should be adjusted when the drug would be co-administerεd chronically with cimetidine in a clinical situation.

Keywords

References

  1. AHFS, Drug Information, ASHP, MD, U.S.A. pp. 1317-1324 (1988)
  2. A. Schwarz. et al., Pharmacology of calcium antagonists, Am. J. Cardiol., 55(7), 3C-7C (1985) https://doi.org/10.1016/0002-9149(85)90798-2
  3. H. Scholz, Pharmacological aspects of calcium channel blockers, Cardiovasc. Drugs Ther., 10, 869-872 (1997) https://doi.org/10.1007/BF00051613
  4. M. Epstein. and R.D, Loutzenhister, Effects of calcium antagonists on renal hemodynamics, Am. J. Kidney Dis., 16, 10-14 (1990)
  5. L.M. Ruilope, and J. M. Alcaar, Renal effects of calcium entry blockers, Cardiovasc. Drugs Ther., 4, 979-82 (1990) https://doi.org/10.1007/BF02018304
  6. P. B. Sterzel, Renal actions of calcium antagonists, J. Cardi- ovasc. Pharmacol., 10, 17-22 (1987)
  7. J.L. Reid. et al., Pharmacokinetics of calcium antagonists, J. Cardiovasc Pharmacol., 12(Suppl 7), S22-S26 (1988) https://doi.org/10.1097/00005344-198812007-00005
  8. M. Eichelbaum and H. Echizen, Clinical pharmacology of calcium antagonists, J. Cardiovasc. Pharmacol., 6, 963-967 (1984) https://doi.org/10.1097/00005344-198400067-00006
  9. G. Bianchetti , M. Regazzi, R. Rondanelli, V. Ascalone and PL. Morselli, Bioavailabiltity of diltiazem as a function of the administered dose, Biopharm. Drug Dispos., 12, 391-401 (1991) https://doi.org/10.1002/bdd.2510120508
  10. W. Homsy. et al., The site of absorption in the small intestine determines diltiazem bioavailability in the rabbit, Pharm. Res., 12(11), 1722-6 (1995) https://doi.org/10.1023/A:1016217822770
  11. P.H. Hermann, S.D. Rodger, G. Remones, J.P. Thenot, D.R. London and P.L. Morselli, Pharmacokinetics of diltiazem after intravenous and oral administration, Eur. J. Clin. Pharmacol., 24, 349-352 (1983) https://doi.org/10.1007/BF00610053
  12. W. Homsy. et al., Metabolism of diltiazem in hepatic and extrahepatic tissues of rabbits,. Pharm. Res., 12(4), 609-14 (1995) https://doi.org/10.1023/A:1016226601988
  13. C.D. Klaassen, M.O. Amdur and J. Doull, Toxicology, McGraw-Hill, New York, U.S.A., pp. 113-186 (1999)
  14. V. Rovei, R. Gomeni, M. Mitchard, J. Larribaud, C. Blatrix, J.J. Thebault and P.L. Morselli, Pharmacokinetics and metabolism of diltiazem in man, Acta Cardiol., 35, 35-45 (1980)
  15. P.K. Yeung, S.J. Mosher, M.A. Quilliam and T. J. Montague, Species comparison of pharmacokinetics and metabolism of diltiazem in humans, dogs, rabbits and rats, Drug Metab. Dispos., 18, 1055-1059 (1990)
  16. P. Hoglund and L.G. Nilsson, Pharmacokinetics of diltiazem and its metabolites after single and multiple dosing in healthy volunteer, Ther. Drug Monit., 11, 558-566 (1998) https://doi.org/10.1097/00007691-198909000-00012
  17. R.H. Levy, K.E, Thummel and W.F. Trager, Metabolic drug interactions, Lippincott Williams & Wilkins, Philadelphia, U.S.A., pp. 653-659 (2000)
  18. L.M. Johnson, S.M. Lankford and S.A. Bai, The influence of cimetidine on the pharmacokinetics of the enantiomers of verapamil in the dog during multiple oral dosing, J. Vet. Pharmacol. Ther., 18, 117-123 (1995) https://doi.org/10.1111/j.1365-2885.1995.tb00564.x
  19. G. Mikus, M. Eichelbaum and C. Fischer, Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug action, J. Pharmacol. Exp. Ther., 253, 1042-1048 (1990)
  20. M.S. Smith, M.C. Benyunes and T.D. Bjornsson, Influence of cimetidine on verapamil kinetics and dynamics, Clin. Pharmacol. Ther., 36, 551-554 (1984) https://doi.org/10.1038/clpt.1984.218
  21. A. Khan, S.J. Langley and F.G. Mullins, The pharmacokinetics and pharmacodynamics of nifedipine at steady state during concomitant administration of cimetidine or high dose ranitidine, Br. J. Clin. Pharmacol., 32, 519-522 (1991) https://doi.org/10.1111/j.1365-2125.1991.tb03943.x
  22. J.B. Schwartz, R.A. Upton and E.T. Lin, Effect of cimetidine or ranitidine administration on nifedipine pharmacokinetics and pharmacodynamics, Clin. Pharmacol. Ther., 43, 673-680 (1988) https://doi.org/10.1038/clpt.1988.94
  23. W. Kirch, K. Ramsch and H.D. Janisch, The influence of two histamine H2-receptor antagonists, cimetidine and ranitidine, on the plasma levels and clinical effect of nifedipine and metoprolol, Arch. Toxicol. Suppl., 7, 256-259 (1984) https://doi.org/10.1007/978-3-642-69132-4_38
  24. L.C. Winship, J.M. Mckenney, J.T. Wright, J.H. Wood and R.P. Goodman, The effect of ranitidine and cimetidine on singledoes diltiazem pharmacokinetics, Pharmacotherapy, 5, 16-9 (1985) https://doi.org/10.1002/j.1875-9114.1985.tb04451.x
  25. M. Mazher, K.D. Popat and C. Sanders, Effect of cimetidine diltiaem blood levels, Clin. Res., 32, 741A (1984)
  26. K.J. Goebel and E.U. Kolle, High performance liquid chromatographic dertermination of diltiazem and four of its metabolites in plasma, J. Chromatogr., 345, 355-363 (1985) https://doi.org/10.1016/0378-4347(85)80172-9
  27. M.L. Rocci and W.J. Jusko, LAGRAN program for area and moments in pharmacokinetic analysis, Computer program in Biomedicine, 16, 203-211 (1983) https://doi.org/10.1016/0010-468X(83)90082-X
  28. J.S. Choi and J.H. Lee, Pharmacokinetics of diltiazem and major metabolite ,desacetyldiltiazem after oral administered of diltiazem in mild medium Folate-Induced renal failre rabbits, Arch. Pharm. Res., 24, 333-337 (2001) https://doi.org/10.1007/BF02975102
  29. J.S. Choi and Y.G. Kim, Pharmacokinetic changes of diltiazem and desacetyldiltiazem after oral administration of diltiazem in rabbits with diabetes mellitus induced alloxan, Biopharm. Drug Dispos., 23, 115-120 (2002) https://doi.org/10.1002/bdd.298